Virtus Fund Advisers, LLC Intercept Pharmaceuticals, Inc. Transaction History

Virtus Fund Advisers, LLC

  • $20.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$12.53 - $21.71 $18,281 - $31,674
1,459 New
1,459 $19,000
Q3 2022

Nov 14, 2022
SELL
$12.21 - $19.7 $189,767 - $306,177
-15,542 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$58.2 - $72.76 $904,544 - $1.13 Million
15,542
15,542 $908,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email